00000000cam 2200000zi 4500
0019.965446
003CaOODSP
00520260904133341
006m     o  d f      
007cr cn|||||||||
008260826e20250516oncd    obs  f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH82-61/2025E-PDF
1001 |aGaudette, Étienne, |d1953- |eauthor.
24510|aDrug shortage in focus : |bwhy competition is key / |cÉtienne Gaudette, PhD.
264 1|a[Ottawa] : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |cMay 16, 2025.
300 |a1 online resource (8 pages) : |bcharts
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Pénuries de médicaments en bref : l’importance de la concurrence.
500 |a"ISPOR 2025 Meeting."
504 |aIncludes bibliographical references (page 7).
650 0|aDrug accessibility|zCanada|vStatistics.
650 0|aDrugs|xSupply and demand|zCanada|vStatistics.
655 7|aStatistics|2lcgft
7101 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body.
77508|tPénuries de médicaments en bref : |w(CaOODSP)9.965673
85640|qPDF|s540 KB|uhttps://publications.gc.ca/collections/collection_2026/cepmb-pmprb/H82-61-2025-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/slide-presentations/ispor2025-drug-shortages.html